Ondansetron HCL 4 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FHQQS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,842
Award facts
- Contract value 100% obligated
- $28,842.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Ondansetron HCL 4 mg tablets (30-count units) valued at $28.8K. This contract was competitively awarded with no set-aside designation and utilizes firm fixed-price pricing. The pharmaceutical will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 26, 2025. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.9M through December 2026, which serves as the primary vehicle for pharmaceutical procurement supporting military healthcare systems globally.
As a major pharmaceutical distributor headquartered in Pennsylvania, AmerisourceBergen Drug Corp is a critical federal medical vendor supplying a comprehensive range of medications, vaccines, medical devices, and healthcare commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Ondansetron, a widely-used anti-nausea medication, represents a standard pharmaceutical commodity within the company's extensive portfolio of generic and brand-name drugs supporting military medical operations. The DLA Troop Support Medical contract vehicle enables flexible fulfillment of pharmaceutical requirements across multiple therapeutic domains and serves as the foundation for this and similar delivery order awards.
Quick answers
Who was awarded contract SPE2DB25FHQQS?
SPE2DB25FHQQS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 25, 2025.
How much is contract SPE2DB25FHQQS worth?
The government has obligated $28,842 on SPE2DB25FHQQS.
Is contract SPE2DB25FHQQS an order under another contract?
Yes. SPE2DB25FHQQS is a delivery order under SPE2DB24D2212, an indefinite delivery contract.
Was contract SPE2DB25FHQQS competed?
The extent of competition for SPE2DB25FHQQS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award